Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03105193Phase 4Completed
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by The University of Auckland. Primary endpoint: Morphine consumption at 3 days. Started Aug 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03105193.